Development of Mitochondria-Targeted PARP Inhibitors
PARP inhibitors are a clinically validated class of anticancer therapeutics that exploit synthetic lethality to target homologous recombination-deficient tumors, such as those carrying BRCA1/2 mutations. Nevertheless, the rational design of mitochondria-targeted PARP inhibitors capable of selective...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2026-01-01
|
| Serier: | Biomolecules |
| Fag: | |
| Online adgang: | https://www.mdpi.com/2218-273X/16/1/165 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
